Bryan Giraudo

Bryan Giraudo

Director of Finance/CFO at GOSSAMER BIO, INC.

Net worth: 4 M $ as of 2026-05-30

50 year
Finance
Health Technology
Consumer Services

Profile

Bryan Giraudo is currently an Independent Director at Valerio Therapeutics SA since 2021, an Independent Director at Protagonist Therapeutics, Inc. since 2018, and Chief Financial & Operating Officer at Gossamer Bio, Inc. since 2021.
Former positions include Senior Managing Director at Leerink Partners LLC from 2009 to 2018, Managing Director at Merrill Lynch & Co., Inc. from 1997 to 2009, and Managing Director at Pierce Fenner & Smith, Inc. Education includes an undergraduate degree from Georgetown University conferred in 1997.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-07 40,520 ( 0.06% ) 4 M $ 2026-05-30
2026-04-19 572,747 ( 0.12% ) 132 305 $ 2026-05-30

Bryan Giraudo active positions

CompaniesPositionStart
PROTAGONIST THERAPEUTICS, INC. Director/Board Member 2018-05-15
GOSSAMER BIO, INC. Director of Finance/CFO 2018-05-06
VALERIO THERAPEUTICS Director/Board Member 2021-11-22

Former positions of Bryan Giraudo

CompaniesPositionEnd
Corporate Officer/Principal 2018-04-30
Corporate Officer/Principal 2009-06-30
Corporate Officer/Principal -
See the detail of Bryan Giraudo's experience

Training of Bryan Giraudo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Finance

Finance

Health Technology

Consumer Services

Health Technology

Finance

Health Technology